Advertisements

First Fibroblast Injection Performed in SpinalCyte’s Landmark Trial for Spinal Disc Regeneration

First Fibroblast Injection Performed in SpinalCyte’s Landmark Trial for Spinal Disc Regeneration.....»»

Category: press-releasesSource: businesswireindiaMar 15th, 2017

Boehringer Ingelheim Phase III study now enrolling patients with progressive fibrosing lung diseases

Boehringer Ingelheim Phase III study now enrolling patients with progressive fibrosing lung diseases.....»»

Category: press-releasesSource: businesswireindiaMar 20th, 2017

Uninterrupted Pradaxa® Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation

Uninterrupted Pradaxa® Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation.....»»

Category: press-releasesSource: businesswireindiaMar 20th, 2017

Oral OTEZLA® (Apremilast) Demonstrated Significant Improvement versus Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy

Oral OTEZLA® (Apremilast) Demonstrated Significant Improvement versus Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy.....»»

Category: press-releasesSource: businesswireindiaMar 5th, 2017

South Korean Intellectual Property Trial and Appeal Board Upholds Validity of 3M Korean Patent

South Korean Intellectual Property Trial and Appeal Board Upholds Validity of 3M Korean Patent.....»»

Category: press-releasesSource: businesswireindiaFeb 27th, 2017

Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung

Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung.....»»

Category: press-releasesSource: businesswireindiaFeb 11th, 2017

CellProthera Raises 8.3 Million Euros

CellProthera Raises 8.3 Million Euros.....»»

Category: press-releasesSource: businesswireindiaFeb 3rd, 2017

Continuing to Grow in India, Milacron to Showcase Industry Leading Injection, Extrusion and Hot Runner Technologies at Plastivision 2017, Including the Launch of the New Quantum 150

Continuing to Grow in India, Milacron to Showcase Industry Leading Injection, Extrusion and Hot Runner Technologies at Plastivision 2017, Including the Launch of the New Quantum 150.....»»

Category: press-releasesSource: businesswireindiaJan 17th, 2017

Continuing to Grow in India, Milacron to Showcase Industry Leading Injection, Extrusion and Hot Runner Technologies at Plastivision 2017, Including the Launch of the New Quantum 150

Continuing to Grow in India, Milacron to Showcase Industry Leading Injection, Extrusion and Hot Runner Technologies at Plastivision 2017, Including the Launch of the New Quantum 150.....»»

Category: press-releasesSource: businesswireindiaJan 17th, 2017

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera(TM) for Treatment of Dry Eye

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera(TM) for Treatment of Dry Eye.....»»

Category: press-releasesSource: prnewswireJan 4th, 2017

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera(TM) for Treatment of Dry Eye

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera(TM) for Treatment of Dry Eye.....»»

Category: press-releasesSource: prnewswireJan 4th, 2017

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera(TM) for Treatment of Dry Eye

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera(TM) for Treatment of Dry Eye.....»»

Category: press-releasesSource: prnewswireJan 4th, 2017

Agni-V to undergo 3 months trial now

Agni-V to undergo 3 months trial now.....»»

Category: topSource: economictimesDec 26th, 2016

72,000 "blank calls" plague Delhi Police everyday

72,000 "blank calls" plague Delhi Police everyday.....»»

Category: topSource: economictimesDec 26th, 2016

Successful test firing of India"s most potent missile Agni 5, paves way for induction in Strategic Forces Command

Successful test firing of India"s most potent missile Agni 5, paves way for induction in Strategic Forces Command.....»»

Category: topSource: economictimesDec 26th, 2016

Nifty hits 7- month low; metal, realty, pharma stocks drag

Nifty hits 7- month low; metal, realty, pharma stocks drag.....»»

Category: topSource: business-standardDec 26th, 2016

Nifty hits 7- month low; metal, realty, pharma stocks drag

Nifty hits 7- month low; metal, realty, pharma stocks drag.....»»

Category: topSource: business-standardDec 26th, 2016

Live: PM Modi in Maha for inauguration of Shivaji memorial, Mumbai and Pune metro - Firstpost

Live: PM Modi in Maha for inauguration of Shivaji memorial, Mumbai and Pune metro - Firstpost.....»»

Category: topSource: googlenewsDec 26th, 2016

Real Estate: The year that saw the biggest changes in decades

Real Estate: The year that saw the biggest changes in decades.....»»

Category: real-estateSource: sifyDec 26th, 2016

India conducts fourth experimental trial of Agni-V

India conducts fourth experimental trial of Agni-V.....»»

Category: topSource: business-standardDec 26th, 2016

ONGC to pay over USD1.2 bn for GSPC stake buy

ONGC to pay over USD1.2 bn for GSPC stake buy.....»»

Category: topSource: moneycontrolDec 25th, 2016